Hit enter to search or ESC to close
Expansion Therapeutics
  • Home
  • About
    • Company Overview
    • Our Partners
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Pipeline of Compositions
    • Expansion Repeat Disorders
    • Myotonic Dystrophy Type 1
    • Myotonic Dystrophy Type 2
  • Platform
    • Overview
    • Publications
  • Newsroom
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • Career Opportunities
    • News Alerts
In the News

Expansion into TNBC – BioCentury

By Expansion Therapeutics February 21, 2019 February 25th, 2019 No Comments

Expansion into TNBC – BioCentury

Love0 Share Tweet Share

© 2021 Expansion Therapeutics | Terms of Use | Privacy Policy

  • Home
  • About
    • Company Overview
    • Our Partners
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Pipeline of Compositions
    • Expansion Repeat Disorders
    • Myotonic Dystrophy Type 1
    • Myotonic Dystrophy Type 2
  • Platform
    • Overview
    • Publications
  • Newsroom
  • Contact
    • General Inquiries
    • Partnership Inquiries
    • Career Opportunities
    • News Alerts

Recent News and Insights

  • Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President October 5, 2020
  • Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board June 17, 2019
  • Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs – The Scientist April 1, 2019